American International Group, Inc. Immunity Bio, Inc. Transaction History
American International Group, Inc.
- $27.6 Billion
- Q1 2024
A detailed history of American International Group, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 65,341 shares of IBRX stock, worth $403,807. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,341
Previous 65,902
0.85%
Holding current value
$403,807
Previous $330,000
6.06%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IBRX
# of Institutions
191Shares Held
66.7MCall Options Held
2.27MPut Options Held
3.23M-
State Street Corp Boston, MA14.2MShares$87.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$83.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$64.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.48MShares$21.5 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.55MShares$9.57 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.47B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...